Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary and Q&A session provide a generally positive outlook. The company expects mid-single-digit growth, margin expansion, strategic talent investments, and strong AI integration. The share repurchase plan and optimistic guidance on Health and Wealth segments add to the positive sentiment. However, challenges like Medicare changes and cautious client spending are noted. The overall sentiment is positive, with growth expectations and strategic initiatives outweighing the challenges. The lack of market cap data limits precise prediction, but the sentiment suggests a positive stock price movement.
Organic Growth (Q4) 6% organic growth in the fourth quarter, driven by strategic efforts and steady execution.
Adjusted Operating Margin (Q4) 80 basis points of adjusted operating margin expansion in the fourth quarter, attributed to enhanced efficiency and operational discipline.
Adjusted EPS (Q4) $8.12, a 13% year-over-year increase excluding TRANZACT's $0.80 contribution in Q4 2024.
Organic Growth (Full Year) 5% organic growth for the full year, in line with mid-single-digit target.
Adjusted Operating Margin (Full Year) 130 basis points year-over-year expansion to 25.2%, reflecting operational improvements.
Adjusted EPS (Full Year) $17.08, a 13% year-over-year increase excluding TRANZACT.
Health, Wealth & Career Organic Growth (Q4) 6% organic growth in Q4, with 30 basis points of operating margin expansion excluding TRANZACT.
Risk & Broking Organic Growth (Q4) 7% organic growth in Q4, with 120 basis points of adjusted operating margin expansion.
Corporate Risk & Broking Organic Growth (Q4) 8% organic growth in Q4, marking the 12th consecutive quarter of high single-digit growth, driven by increased M&A activity and new business in specialty lines.
Health Business Growth (Q4) 4% growth in Q4, or 6% excluding book of business settlement activity and interest income headwinds, driven by new business acquisition and renewals.
Wealth Business Growth (Q4) 5% growth in Q4, driven by increased retirement work globally and new solutions in Europe.
Career Growth (Q4) 10% growth in Q4, driven by demand for advisory services, compensation benchmarking, and survey delivery pattern changes.
Benefits Delivery and Outsourcing Growth (Q4) 5% growth in Q4, driven by increased commission revenue in Individual Marketplace business.
Insurance Consulting and Technology Revenue (Q4) Declined 1% in Q4, reflecting continued weakness in consulting and cautious client behavior on technology implementations.
Free Cash Flow (Full Year) $1.5 billion, an increase of $279 million year-over-year, driven by reduced transformation program costs and operating margin expansion.
LifeSight: Continues to gain market share. A Fortune 50 technology company chose LifeSight as its Master Trust pension program in the U.K., adding GBP 400 billion of assets under management.
Digital Infrastructure: Strong and growing presence, supporting 5 of the 10 largest data center developers globally. Recently added one of these developers for their master builders' risk placement.
Construction Specialty: Selected as the commercial insurance broker for two major U.S. bank headquarter renovation projects valued at over $1 billion.
Nordic Industrial Company: Secured a large win supporting insurance, benefits, and pension programs previously handled in-house.
WE DO (AI and Automation): Central to enhancing efficiency, maintaining operational discipline, and creating lasting cost savings. Embedded in enterprise operating model and global delivery centers.
Integration of Newfront: Focused on integrating Newfront's team and technology into WTW, aiming to deliver an integrated end-to-end technology platform.
Portfolio Optimization: Divested TRANZACT and announced acquisitions of Newfront, Cushon, and FlowStone Partners to improve business mix, expand reach, and enhance growth and profitability.
Acquisition of Cushon: Strengthens position in the U.K. defined contribution Master Trust market with innovative technology-led solutions.
Acquisition of FlowStone Partners: Expands access to private markets for individual and institutional investors.
Regulatory and Political Environment: The political and regulatory environment worldwide remains highly dynamic, which could pose challenges for clients and require the company to adapt its advice and solutions.
Macroeconomic Uncertainty: Ongoing macroeconomic uncertainty could impact the company's strategy and financial performance.
Challenging Pricing Environment: The Corporate Risk & Broking business faces a more challenging pricing environment, which could affect growth and profitability.
Medicare Market Changes: Changes in the Medicare market are expected to impact the Benefits Delivery and Outsourcing segment, leading to lower growth in 2026.
Consulting Environment Weakness: The Insurance Consulting and Technology business is experiencing continued weakness in the consulting environment, with clients cautious about making large multiyear technology implementation decisions.
Integration Risks: The integration of Newfront and other acquisitions poses risks, including potential disruption to clients and challenges in achieving synergies.
Foreign Exchange Volatility: Foreign exchange rates could impact adjusted EPS and operating margins, as seen with the tailwind in 2025.
Reinsurance JV Investment: The reinsurance joint venture is expected to be a headwind of about $0.30 to adjusted EPS in 2026.
Revenue Growth: The company expects mid-single-digit organic revenue growth in 2026, supported by strong momentum in the market and steady progress in executing its strategy.
Health Business Growth: The Health business is projected to deliver high single-digit growth in 2026, driven by healthcare inflation and employers' focus on managing costs while maintaining competitive employee benefits.
Wealth Business Growth: The Wealth business is expected to grow at the high end of the low single-digit range in 2026, supported by demand for core defined benefit work and new solutions in Europe.
Career Business Growth: The Career business is projected to achieve mid-single-digit growth in 2026, driven by product and technology offerings, recurring services, and increased demand for advisory services.
Benefits Delivery and Outsourcing (BD&O) Growth: BD&O is expected to achieve low single-digit growth in 2026, with growth concentrated in the fourth quarter due to changes in the Medicare market.
Corporate Risk & Broking (CRB) Growth: CRB is expected to deliver mid- to high single-digit growth in 2026, supported by the specialization strategy and investments in talent, data, and technology.
Insurance Consulting and Technology (ICT) Growth: ICT is projected to achieve low to mid-single-digit growth in 2026, with a focus on shifting the balance from consulting to technology.
Adjusted Operating Margin Expansion: The company aims to deliver 100 basis points of average annual adjusted operating margin expansion over the next two years.
Free Cash Flow Margin Expansion: Free cash flow margin is expected to expand in 2026, driven by operating margin expansion and the absence of transformation program cash costs.
Capital Allocation: The company plans to allocate at least $1 billion to share repurchases in 2026, subject to market conditions and investment opportunities.
Acquisition Integration: The company will focus on integrating recent acquisitions, including Newfront, Cushon, and FlowStone Partners, to drive growth, enhance efficiency, and generate synergies over the next three years.
Dividends Paid in Q4 2025: $89 million
Total Dividends Paid in 2025: $2 billion
Future Dividend Plans: No specific future dividend plans mentioned
Share Repurchases in Q4 2025: $350 million
Total Share Repurchases in 2025: $2 billion
Future Share Repurchase Plans: At least $1 billion allocated for share repurchases in 2026, subject to market conditions and investment opportunities
The earnings call summary and Q&A session provide a generally positive outlook. The company expects mid-single-digit growth, margin expansion, strategic talent investments, and strong AI integration. The share repurchase plan and optimistic guidance on Health and Wealth segments add to the positive sentiment. However, challenges like Medicare changes and cautious client spending are noted. The overall sentiment is positive, with growth expectations and strategic initiatives outweighing the challenges. The lack of market cap data limits precise prediction, but the sentiment suggests a positive stock price movement.
The earnings call summary indicates strong financial performance with margin improvements and growth in key segments like Health and Risk & Broking. The company's strategic focus on technology, geographic expansion, and shareholder returns through share repurchases bolster positive sentiment. The Q&A section confirms confidence in growth projections and highlights ongoing demand despite pricing challenges. Analysts' inquiries about margin improvements and growth strategies received satisfactory responses, further supporting a positive outlook. However, the lack of specific guidance for 2026 and some unclear responses slightly temper the sentiment, resulting in an overall positive rating.
The earnings call summary and Q&A highlight strong organic growth, margin expansion, and strategic initiatives like technology investments and acquisitions. Positive factors include a $1.5 billion share repurchase plan, optimistic guidance for mid-single-digit growth, and double-digit growth in specialty areas. Despite concerns over cash tax payments and competitive talent acquisition, the overall sentiment is positive, with management's strategic focus and optimistic outlook likely to boost stock price by 2% to 8%.
The earnings call presents a generally positive outlook. Financial performance shows solid growth with a 5% organic revenue increase and an 8% rise in EPS. The adjusted operating margin also improved. Shareholder returns are robust, with $288 million returned and a substantial share repurchase plan. Despite a negative free cash flow, guidance and business updates are optimistic. The Q&A reveals confidence in overcoming economic uncertainties and strategic focus on growth. These factors, especially the share repurchase plan, suggest a positive short-term stock price movement.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.